US4577301090
US4577301090
Inspire Medical Systems, Inc.
Loading chart...
Company Profile
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Latest News

StockStory • 10/08/2026
3 Cash-Heavy Stocks We Steer Clear Of

The Fly • 10/07/2026
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
MT Newswires • 10/07/2026
Barclays Initiates Inspire Medical Systems at Underweight With $65 Price Target

StockStory • 10/06/2026
1 Profitable Stock Worth Your Attention and 2 We Ignore

GlobeNewswire • 10/05/2026
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026

Simply Wall St. • 10/05/2026
How Investors Are Reacting To Inspire Medical Systems (INSP) Securing Category I CPT Codes For Inspire V
Related stocks
Key Metrics & Overview
Detailed metrics & financial data of the company
Company Profile
5
MetricsCountry
Region
Sector
Industry
Website
🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
7/7 Very High
5Y Volatility
61.0% p.a.
Max Drawdown (5Y)
-87.7%
Sharpe Ratio (5Y)
-0.40
Beta Factor
0.73
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Elevated Short-Term Volatility: 3Y volatility (67.8%) is noticeably higher than the 5Y average (61.0%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (61.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -87.7% in the extended horizon.